M. Wouter Dercksen

1.3k total citations
38 papers, 834 citations indexed

About

M. Wouter Dercksen is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Wouter Dercksen has authored 38 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Wouter Dercksen's work include Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (11 papers). M. Wouter Dercksen is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), HER2/EGFR in Cancer Research (12 papers) and Advanced Breast Cancer Therapies (11 papers). M. Wouter Dercksen collaborates with scholars based in Netherlands, United States and Germany. M. Wouter Dercksen's co-authors include Saskia Houterman, Harm R. Haak, Lonneke V. van de Poll‐Franse, J.W.W. Coebergh, M.L.G. Janssen‐Heijnen, Agnès J. van de Wouw, Maaike de Boer, Roel J.W. van Kampen, Vivianne C. G. Tjan‐Heijnen and Adri C. Voogd and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

M. Wouter Dercksen

34 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Wouter Dercksen Netherlands 12 584 283 279 257 119 38 834
Antonio De Leo Italy 17 228 0.4× 230 0.8× 155 0.6× 191 0.7× 71 0.6× 101 869
A.H. Honkoop Netherlands 10 298 0.5× 107 0.4× 211 0.8× 135 0.5× 47 0.4× 20 577
Maria Ignez Braghiroli Brazil 14 583 1.0× 302 1.1× 147 0.5× 210 0.8× 70 0.6× 58 901
Timothy P. Spiro United States 14 289 0.5× 132 0.5× 161 0.6× 260 1.0× 86 0.7× 32 700
Raphael Brandão Moreira United States 11 504 0.9× 369 1.3× 99 0.4× 106 0.4× 52 0.4× 30 719
Amit Mehta United States 12 183 0.3× 300 1.1× 115 0.4× 197 0.8× 56 0.5× 18 667
Akthar Shamsaldin France 11 227 0.4× 216 0.8× 109 0.4× 126 0.5× 106 0.9× 11 768
Panos Fidias United States 13 588 1.0× 637 2.3× 99 0.4× 205 0.8× 189 1.6× 19 1.2k
Tiehong Zhang China 17 280 0.5× 275 1.0× 162 0.6× 242 0.9× 26 0.2× 36 712
Semen Önder Türkiye 16 208 0.4× 138 0.5× 195 0.7× 79 0.3× 71 0.6× 80 730

Countries citing papers authored by M. Wouter Dercksen

Since Specialization
Citations

This map shows the geographic impact of M. Wouter Dercksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Wouter Dercksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Wouter Dercksen more than expected).

Fields of papers citing papers by M. Wouter Dercksen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Wouter Dercksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Wouter Dercksen. The network helps show where M. Wouter Dercksen may publish in the future.

Co-authorship network of co-authors of M. Wouter Dercksen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Wouter Dercksen. A scholar is included among the top collaborators of M. Wouter Dercksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Wouter Dercksen. M. Wouter Dercksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geurts, Sandra M. E., Jolien Tol, Birgit E. P. J. Vriens, et al.. (2025). Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study. The Breast. 84. 104583–104583.
2.
Dercksen, M. Wouter, et al.. (2024). Results of the Dutch scalp cooling registry in 7424 patients: analysis of determinants for scalp cooling efficacy. The Oncologist. 29(10). e1386–e1395. 1 indexed citations
3.
Geurts, Sandra M. E., Frans Erdkamp, Joan B. Heijns, et al.. (2024). Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry. Breast Cancer Research and Treatment. 205(2). 287–302. 3 indexed citations
4.
Vriens, Ingeborg J. H., Sanne Engelen, Frans Erdkamp, et al.. (2023). The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment. 203(2). 339–349. 4 indexed citations
5.
Geurts, Sandra M. E., Frans Erdkamp, M. Wouter Dercksen, et al.. (2023). Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry. The Lancet Regional Health - Europe. 26. 100573–100573. 15 indexed citations
6.
Geurts, Sandra M. E., Frans Erdkamp, Joan B. Heijns, et al.. (2023). Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry. Clinical Breast Cancer. 24(2). 103–111. 1 indexed citations
7.
Geurts, Sandra M. E., Frans Erdkamp, Joan B. Heijns, et al.. (2023). Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry. Breast Cancer Research and Treatment. 198(2). 239–251. 7 indexed citations
8.
Zwan, Jan Maarten van der, Stefan A.W. Bouwense, M. Wouter Dercksen, et al.. (2022). Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study. European Journal of Cancer. 172. 252–263. 16 indexed citations
9.
Geurts, Sandra M. E., Frans Erdkamp, M. Wouter Dercksen, et al.. (2021). The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry. International Journal of Cancer. 150(1). 124–131. 10 indexed citations
10.
Geurts, Sandra M. E., Frans Erdkamp, M. Wouter Dercksen, et al.. (2021). 248P The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE registry. Annals of Oncology. 32. S468–S469. 1 indexed citations
11.
Riet, Job van, Harmen J.G. van de Werken, Edwin Cuppen, et al.. (2021). The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nature Communications. 12(1). 4612–4612. 69 indexed citations
12.
Geurts, Sandra M. E., Sander Croes, Frans Erdkamp, et al.. (2021). Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry. Breast Cancer Research and Treatment. 188(2). 571–581. 7 indexed citations
13.
14.
15.
Kampen, Roel J.W. van, Bram Ramaekers, D.J.A. Lobbezoo, et al.. (2017). Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium. European Journal of Cancer. 79. 238–246. 12 indexed citations
16.
Lobbezoo, D.J.A., Wilfred Truin, Adri C. Voogd, et al.. (2016). The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches. Oncotarget. 7(20). 29412–29419. 9 indexed citations
17.
Cirkel, Geert A., Paul Hamberg, Stefan Sleijfer, et al.. (2016). Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer. JAMA Oncology. 3(4). 501–501. 25 indexed citations
18.
Charehbili, Ayoub, Saskia van de Ven, Vincent T.H.B.M. Smit, et al.. (2014). Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). Annals of Oncology. 25(5). 998–1004. 31 indexed citations
19.
Dercksen, M. Wouter, et al.. (2013). Hair mass index obtained by cross-section trichometry: an objective and clinically useful parameter to quantify hair in chemotherapy-induced alopecia. Supportive Care in Cancer. 21(7). 1807–1814. 6 indexed citations
20.
Dercksen, M. Wouter, et al.. (2012). Evaluation of Cohen's Cross-Section Trichometer for Measuring Hair Quantity. Dermatologic Surgery. 38(4). 631–634. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio De Leo Breakdown of academic impact, for papers by A.H. Honkoop Breakdown of academic impact, for papers by Maria Ignez Braghiroli Breakdown of academic impact, for papers by Timothy P. Spiro Breakdown of academic impact, for papers by Raphael Brandão Moreira Breakdown of academic impact, for papers by Amit Mehta Breakdown of academic impact, for papers by Akthar Shamsaldin Breakdown of academic impact, for papers by Panos Fidias Breakdown of academic impact, for papers by Tiehong Zhang Breakdown of academic impact, for papers by Semen Önder
Rankless by CCL
2026